Role of insulin-like growth factors (IGFs), their receptors and genetic regulation in the chondrogenesis and growth of the mandibular condylar cartilage

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 1796-1804

  Patil, Amol S ^a   Sable, Ravindra B ^a   Kothari, Ramanlal M ^b  

^a Bharati Vidyapeeth University Dental College and Hospital   (India)

^b Bharati Vidyapeeth Deemed University   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; INTEGRIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

BINDING SITE; CARTILAGE; CARTILAGE CELL; CHONDROGENESIS; GENETIC REGULATION; HUMAN; MANDIBULAR CONDYLAR CARTILAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CHONDROCYTES; CHONDROGENESIS; EPIGENESIS, GENETIC; GENE EXPRESSION; HUMANS; INTEGRINS; INTERLEUKIN-1; MANDIBULAR CONDYLE; OSTEOARTHRITIS; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS;

EID: 84856188285     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22905     Document Type: Review

References (115)

1. Asanbaeva A, Masuda K, Thonar EJ-MA, Klisch SM, Sah RL. 2008. Regulation of immature cartilage growth by IGF-I, TGF-β-1, BMP-7 and PDGF-AB: Role of metabolic balance between fixed charge and collagen network. Biomech Model Mechanobiol 7: 263-276.
2. Bak JF, Moller N, Schmitz O. 1991. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 260: E736-E742.
3. Baker J, Liu JP, Robertson EJ, Efstratiadis A. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
4. Barreca A, Artini PG, Cesarone A, Arvigo M, D'Ambrogio G, Genazzani AR, Giordano G, Minuto F. 1996. Interrelationships between follicle stimulating hormone and the growth hormone-insulin-like growth factor-IGF-binding proteins axis in human granulosa cells in culture. J Endocrinol Invest 19: 35-42.
5. Bell GI, Stempien MM, Fong NM, Rall LB. 1986. Sequences of liver cDNAs encoding two different mouse insulin like growth factor-1 precursors. Nucleic Acid Res 14: 7873-7882.
6. Bhattacharyya N, Pechhold K, Shahjee H, Zappala G, Elbi C, Raaka B, Wiench M, Hong J, Rechler MM. 2006. Non-secreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF independent mechanisms without being concentrated in the nucleus. J Biol Chem 281: 24588-24601.
7. Blumenfeld I, Livne E. 1999. The role of transforming growth factor (TGF-β), insulin-like growth factor (IGF)-1 and interleukin (IL)-1 in osteoarthritis and aging of joints. Exptl Gerontol 34: 821-829.
8. Blumenfeld I, Gasper R, Laufer D, Livne E. 2000. Enhancement of toluidine blue staining by transforming growth factor, insulin like growth factors and growth hormone in the temporomandibular joint of aged mice. Cells Tissues Organs 167: 121-129.
9. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. 1991. Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 260: E846-E851.
10. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. 1994. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 93: 1131-1139.
11. Bujia J, Pitzke P, Kastenbauer E, Wilmes E, Hammer C. 1996. Effect of growth factors on matrix synthesis by human nasal chondrocytes cultured in monolayer and in agar. Eur Arch Otorhinolaryngol 253: 336-340.
12. Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK. 2005. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer 41: 1515-1527.
13. Burroughs KD, Dunn SE, Barrett JC. 1999. Insulin-like growth factor I: A key regulator of human cancer risk. J Natl Cancer Inst 91: 579-581.
14. Butt AJ, Fraley KA, Firth SM, Baxter RC. 2002. IGF-binding protein- 3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinol 143: 2693-2699.
15. Chubinskaya S, Kuettner KE. 2003. Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol 35: 1323-1340.
16. Clemmons DR. 2006. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 6: 620-625.
17. Cobb LJ, Liu B, Lee KW, Cohen P. 2006. Phosphorylation by DNA dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3. Cancer Res 66: 10878-10884.
18. Daughaday WH, Rotwein P. 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10: 68-91.
19. Delatte M, von den Hoff JW, Malthaa JC, Kuijpers-Jagtmana AM. 2004. Growth stimulation of mandibular condyles and femoral heads of newborn rats by IGF-I. Arch Oral Biol 49: 165-175.
20. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT. 2007. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 27: 3569-3577.
21. Eivindson M, Nielsen JN, Gronbaek H, Flyvbjerg A, Hey H. 2005. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease. Horm Res 64: 9-15.
22. Elder BD, Athanasiou KA. 2009. Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs. Osteoarthritis Cartilage 17: 114-123.
23. Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ. 1996. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10: 286-297.
24. Fanayan S, Firth SM, Butt AJ, Baxter RC. 2000. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor. J Biol Chem 275: 39146-39151.
25. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
26. Froesch ER, Buergi H, Ramseier EB, Bally P, Labhart A. 1963. Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiologic significance. An insulin assay with adipose tissue of increased precision and specificity. J Clin Invest 42: 1816-1834.
27. Froesch ER, Muller WA, Burgi H, Waldvogel M, Labhart A. 1966. Non-suppressible insulin-like activity of human serum. II Biological properties of plasma extracts with non-suppressible insulin-like activity. Biochim Biophys Acta 121: 360-374.
28. Froesch ER, Schmid C, Schwander J, Zapf J. 1985. Actions of insulin like growth factors. Ann Rev Physiol 47: 443-467.
29. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. 1999. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes. Diabetes Metab Res Rev 15: 314-322.
30. Fuentes MA, Opperman LA, Bellinger LL, Carlson DS, Hinton RJ. 2002. Regulation of cell proliferation in rat mandibular condylar cartilage in explant culture by insulin-like growth factor-1 and fibroblast growth factor-2. Arch Oral Biol 47: 643-654.
31. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. 2000. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-349.
32. Goodman-Gruen D, Barrett-Connor E. 1997. Epidemiology of Insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol 145: 970-976.
33. Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ. 1989. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J. Bone Joint Surg 89: 672-685.
34. Guler HP, Zapf J, Froesch ER. 1987. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317: 137-140.
35. Harrela HM, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppälä M. 1996. Genetic and environmental components of inter-individual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J Clin Invest 98: 2612-2615.
36. Hinton RJ, Carlson DS. 2005. Regulation of growth in mandibular condylar cartilage. Semin Orthod 11: 209-218.
37. Hirota Y, Tsukazaki T, Yonekura A, Miyazaki Y, Osaki M, Shindo H. 2000. Activation of specific MEK-ERK cascade is necessary for TGF-β signaling and crosstalk with PKA and PKC pathways in cultured articular chondrocytes. Osteoarthritis Cartilage 8: 241-248.
38. Hochscheid R, Jaques G, Wegmann B. 2000. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: A cell culture model for lung cancer. J Endocrinol 166: 553-563.
39. Holland TA, Bodde EW, Cuijpers VM, Baggett LS, Tabata Y, Mikos AG, Jansen JA. 2007. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage 15: 187-197.
40. Holzenberger M, Kappeler L, De Magalhaes FC. 2004. IGF-1 signaling and aging. Exp Gerontol 39: 1761-1764.
41. Hong J, Zhang G, Dong F, Rechler MM. 2002. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277: 10489-10497.
42. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. 2004. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700.
43. Hui W, Rowan AD, Cawston T. 2001. Modulation of expression of matrix metalloproteinases by TGF-β1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-α. Cytokine 16: 31-35.
44. Hwa V, Oh Y, Rosenfeld RG. 1999. The insulin-like growth factor binding protein (IGFBP) superfamily. Endocr Rev 20: 761-787.
45. Itoh K, Suzuki S, Kuroda T. 2003. Effect of local administration of IGF-I on the growth of mandibular condyle of rat. J Med Dent Sci 50: 79-85.
46. Janssen JA, Lamberts SW. 1999. Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis? J Endocrinol Invest 22: 313-315.
47. Jenkins P, Bustin S. 2004. Evidence for a link between IGF-I and cancer. Eur J Endocrinol 151: S17-S22.
48. Johns DE, Athanasiou KA. 2008. Growth factor effects on costal chondrocytes for tissue engineering fibrocartilage. Cell Tissue Res 333: 439-447.
49. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: Biological functions. Endocr Rev 16: 3-34.
50. Juul A. 2003. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13: 113-170.
51. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE. 1994. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78: 744-752.
52. Kaaks R, Toniolo P, Akhmedkhadnov A, Lukanova A, Biessy C, Dechaud H. 2000. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592-1600.
53. Kaplan RC, Strickler HD, Rohan TE, Muzumdar R, Brown DL. 2005. Insulin-like growth factors and coronary heart disease. Cardiol Rev 13: 35-39.
54. Kaushal K, Heald AH, Siddals KW, Sandhu MS, Dunger DB, Gibson JM, Wareham NJ. 2004. The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care 27: 2682-2688.
55. Kecha O, Brilot F, Martens H, Franchimot N, Renard C, Greimers R, Defresne MP, Winkler R, Geenen V. 2000. Involvement of insulin like growth factor in early T cell development: A study using fetal thymic organ culture. Endocrinol 141: 1209-1217.
56. Kelijman M. 1991. Age-related alterations of the growth hormone/insulin-like-growth-factor I axis. J Am Geriatr Soc 39: 295-307.
57. Khandwala HM, McCutcheon IE, Flyvbjerg A. 2000. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244.
58. Kim JJ, Accili D. 2002. Signalling through IGF-I and insulin receptors: Where is the specificity? Growth Horm IGF Res 12: 84-90.
59. Le Roith D, Werner H, Beitner-Johnson D, Roberts CT, Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocr Rev 16: 143-163.
60. Lee KW, Cohen P. 2002. Nuclear effects: Unexpected intracellular actions of insulin-like growth factor binding protein-3. J Endocrinol 175: 33-40.
61. Lee KW, Ma L, Yan X, Liu B, Zhang XK, Cohen P. 2005. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRα/Nur77. J Biol Chem 280: 16942-16948.
62. Li G, Barrett EJ, Wang H, Chai W, Liu Z. 2005. Insulin at physiological concentrations selectively activates insulin, but not Insulin-like growth factor-I (IGF-I) or Insulin/IGF-I hybrid receptors in endothelial cells. Endocrinol 146: 4690-4696.
63. Loeser RF. 1997. Growth factor regulation of chondrocyte integrins. Arthritis Rheum 40: 270-276.
64. Loser RF, Pacione CA, Chubinskaya S. 2003. The combination of insulin like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes. Arthritis Rheum 48: 2188-2196.
65. Luna AM, Wilson DM, Wibbelsman CJ, Brown RC, Nagashima RJ, Hintz RL, Rosenfeld RG. 1983. Somatomedins in adolescence: A cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J Clin Endocrinol Metab 57: 27120-27126.
66. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH. 1999. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625.
67. Masoud M, Masoud I, Kent RL, Gowharji N, Cohene LE. 2008. Assessing skeletal maturity by using blood spot insulin-like growth factor I (IGF-I) testing. Am J Orthod Dentofacial Orthop 134: 209-216.
68. Meier C, Parmantier E, Brenan A, Mirsky R, Jessen KR. 1999. Developing Schwann cell acquire the ability to survive without axons by establishing an autocrine circuit involving insulin like growth factor, neutrophin-3 and platelet derived growth factor. J Neurosci 19: 3847-3859.
69. Mi Z, Ghivizzani SC, Lechman ER. 2000. Adenovirus-mediated gene transfer of insulin-like growth factor-I stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum 43: 2563-2570.
70. Modan-Moses D, Janicot M, McLenithan JC, Lane MD, Casella SJ. 1998. Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3- L1 preadipocytes. Biochem J 333: 825-831.
71. Moller DE, Yokota A, Caro JF, Flier JS. 1989. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3: 1263-1269.
72. Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR. 1996. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 45: 91-100.
73. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA. 1990. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 9: 2409-2413.
74. Neidel R, Schulze M, Sova L. 1994. Insulin-like growth factor I accelerates recovery of articular cartilage proteoglycan synthesis in culture after inhibition by interleukin-1. Arch Orthopaed Trauma Surg 114: 43-48.
75. Nielsen FC, Wang E, Gammeltoft S. 1991. Receptor binding, endocytosis, and mitogenesis of insulin-like growth factors I and II in fetal rat brain neurons. J Neurochem 56: 12-21.
76. Olney RC, Tsuchiya K, Wilson DM, Mohtai M, Maloney WJ, Schurman DJ, Smith RL. 2011. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-1) and IGF-binding protein-3 (IGFBP- 3) and -5, but not IGF-2 or IGFBP-4. J Clin Endocrinol Metabol 81: 1096-1103.
77. Oufattole M, Lin SW, Liu B, Mascarenhas D, Cohen P, Rodgers BD. 2006. Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3. Endocrinology 147: 2138-2146.
78. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. 2002. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277: 39684-39695.
79. Patil AS. 2011. Evaluation of condylar growth as a function of growth factors (TGF-β and IGF-1) in young rabbits with and without mandibular advancement. Ph.D. Thesis, Bharati Vidyapeeth Deemed University, Pune (India).
80. Patil AS, Sable RB, Kothari RM. 2011a. An update on transforming growth factor-β (TGF-β): Sources, types, functions and clinical applicability for cartilage/bone healing. J Cell Physiol (in press).
81. Patil AS, Sable RB, Kothari RM. 2011b. Occurrence, biochemical profile of vascular endothelial growth factor (VEGF) isoforms and their functions in endochondral ossification. J Cell Physiol (in press).
82. Pollak M. 2000. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36: 1224-1228.
83. Rajah R, Katz L, Nunn S, Solberg P, Beers T, Cohen P. 1995. Insulin like growth factor binding protein (IGFBP) proteases: Functional regulators of cell growth. Prog Growth Factor Res 6: 273-284.
84. Rajah R, Valentinis B, Cohen P. 1997. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β-1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272: 12181-12188.
85. Rajah R, Khare A, Lee PD, Cohen P. 1999. Insulin-like growth factor binding protein-3 is partially responsible for high-serum induced apoptosis in PC-3 prostate cancer cells. J Endocrinol 163: 487-494.
86. Rajah R, Lee KW, Cohen P. 2002. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: Role of Bcl-2 phosphorylation. Cell Growth Differ 13: 163-171.
87. Rappolee DA, Sturm KS, Behrendtsen O, Schulz GA, Pedersen RA, Werb Z. 1992. Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Develop 6: 939-952.
88. Reinholz GG, Fitzsimmons JS, Casper ME, Ruesink TJ, Chung HW, Schagemann JC, O'Driscoll SW. 2009. Rejuvenation of periosteal chondrogenesis using local growth factor injection. Osteoarthritis Cartilage 17: 723-734.
89. Rinderknecht E, Humbel RE. 1978. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253: 2769-2776.
90. Rodgers BD, Roalson EH, Thompson C. 2008. Phylogenetic analysis of the insulin-like growth factor binding protein (IGFBP) and IGFBP-related protein gene families. Gen Comp Endocrinol 155: 201-207.
91. Rosenfeld RG, Hwa V, Wilson E, Plymate SR, Oh Y. 2000. The insulin-like growth factor-binding protein superfamily. Growth Horm IGF Res 10: S16-S17.
92. Russell-Jones DL, Bates AT, Umpleby AM. 1995. A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest 25: 403-411.
93. Sacco A, Doyonnas R, Labarge MA, Hammer MM, Kraft P, Blau HM. 2005. IGF-1 increases bone marrow contribution to adult skeletal muscles and enhances the fusion of myelomonocytic precursors. J Cell Biol 171: 483-492.
94. Sakai K, Lowman HB, Clemmons DR. 2002. Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2cells in culture. J Biol Chem 277: 13620-13627.
95. Schmidmaier G, Wildemann B, Heeger J, Gäbelein T, Flyvbjerg A, Bail HJ, Raschke M. 2002. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-β1. Bone 31: 165-172.
96. Smith RL, Palathumpat MV, Ku CW, Hintz RL. 1989. Growth hormone stimulates insulin-like growth factor actions on adult articular chondrocytes. J Orthopaed Res 7: 198-207.
97. Smith GD, Gunnell D, Holly J. 2000. Cancer and insulin-like growth factor-I: A potential mechanism linking the environment with cancer risk. BMJ 321: 847-848.
98. Steiner AF, Nöth U, Tuan RS. 2008. Concepts in gene therapy for cartilage repair. Injury 39: 97-113.
99. Suzuki S, Itoh K, Ohyama K. 2004. Local administration of IGF-I stimulates the growth of mandibular condyle in mature rats. J Orthod 31: 138-143.
100. Sviri GE, Blumenfeld I, Livne LZ. 2000. Differential metabolic responses to local administration of TGF-β and IGF-1 in temporomandibular joint cartilage of aged mice. Arch Gerontol Geriatr 31: 159-176.
101. Taylor MW, Simon AE, Kothari RM. 1985. The APRT system. In: Gottesman MM, editor. Molecular cell genetics. New York, USA: John Wiley and Sons. pp 311-332.
102. Thissen JP, Ketelslegers JM, Underwood LE. 1994. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15: 80-101.
103. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. 1994. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 42: 145-151.
104. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. 1995. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9: 361-367.
105. van der Kraan PM, Vitters EL, Postma NS, Verbunt J. 1993. Maintenance of the synthesis of large proteoglycans in anatomically intact murine articular cartilage by steroids and insulin-like growth factor I. Ann Rheum Dis 52: 734-741.
106. Visnapuul V, Peltomaki T, Ronning B, Vahlberg T, Helenius H. 2001. Growth hormone and insulin-like growth factor receptors in the temporomandibular joint of the rat. J Dent Res 80: 1903-1907.
107. von den Hoff JW, Delatte M. 2008. Interplay of mechanical loading and growth factors in the mandibular condyle. Arch Oral Biol 53: 709-715.
108. Wang L, Detamore MS. 2009. Effects of growth factors and glucosamine on porcine mandibular condylar cartilage cells and hyaline cartilage cells for tissue engineering applications. Arch Oral Biol 54: 1-5.
109. Watahiki J, Yamaguchi T, Irie T, Nakano H, Mak K, Tachikawa T. 2004. Gene expression profiling of mouse condylar cartilage during mastication by means of laser microdissection and cDNA array. J Dent Res 83: 245-249.
110. Yokota T, Shimokawa H, Shibata S, Itoh K, Baba Y, Ohya K. 2008. Insulin-like growth factor-1 regulates apoptosis in condylar cartilage. J Dent Res 87: 159-163.
111. Yu H, Rohan T. 2000. Role of insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92: 1472-1489.
112. Yu H, Mistry J, Nicar MJ, Yu H, Khosravi MJ, Diamandis A, van Doorn J, Juul A. 1999. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal 13: 166-172.
113. Zapf J, Schmid C, Froesch ER. 1984. Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab 13: 3-30.
114. Zofkova I. 2003. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res 52: 657-679.
115. Zumstein P, Stiles CD. 1987. Molecular cloning of gene sequences that are regulated by insulin like growth factor-1. J Biochem 262: 11252-11260.